ASCENDIS PHARMA A/S |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 112.93 USD | -1.59% |
|
-5.50% | -10.34% |
| 11:05am | Ascendis Pharma Gets FDA Orphan Drug Designation for Hypoparathyroidism Treatment | MT |
| Sep. 11 | Ascendis Pharma Gets Orphan Drug Exclusivity for Hormone Treatment Yorvipath in U.S. | DJ |
Sales 2023 by Business Segment
Sales 2023 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
Biological Products | ||||||||||
Biotechnology | 13.38M | 6.95M | 7.78M | 51.17M | 267M | |||||
Total Assets | 677M | 980M | 1.08B | 1.09B | 826M | |||||
Interest Expense | -1.22M | -1.92M | -3.91M | -30.68M | -44.06M | |||||
Income Tax Expense | -234K | -219K | -367K | 5.38M | 7.3M | |||||
CAPEX | -5.16M | -21.55M | -24.23M | -14.49M | -2.44M | |||||
EBT | -218M | -419M | -384M | -578M | -474M | |||||
Gross Profit | - | - | 4.26M | 39.04M | 222M | |||||
D&A | 6.69M | 9.45M | 14.95M | 17.51M | 18.43M | |||||
Operating Income | -227M | -331M | -452M | -562M | -456M | |||||
Net Income | -218M | -419M | -384M | -583M | -481M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
North America | 2.65M | 2.68M | 6.86M | 44.16M | 192M | |||||
Total Assets | 27.28M | 85.48M | 91.76M | 89.44M | 68.59M | |||||
Total Assets | 15.74M | 20.29M | 29.66M | 30.34M | 32.89M | |||||
Asia | - | - | - | - | 74.17M | |||||
Europe | - | - | - | 552K | 869K | |||||
Total Assets | - | - | - | - | 13.57M | |||||
China | 10.72M | 4.27M | 922K | 6.47M | - | |||||
Total Assets | 17M | 126M | 148M | 32.34M | 7.81M | |||||
Switzerland | - | - | - | - | - | |||||
Germany | - | - | - | - | - | |||||
Total Assets | 5.55M | 8.06M | 9.91M | 14.15M | - | |||||
United States of America (USA) | - | - | - | - | - |
- Stock Market
- Equities
- ASND Stock
- Financials Ascendis Pharma A/S
- Business Segments